AIM2

Chr 1

absent in melanoma 2

Also known as: PYHIN4

AIM2 is a member of the IFI20X /IFI16 family. It plays a putative role in tumorigenic reversion and may control cell proliferation. Interferon-gamma induces expression of AIM2. [provided by RefSeq, Jul 2008]

ResearchGenerating clinical summary…
DNmechanismLOEUF 1.64
Clinical SummaryAIM2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
36 VUS of 53 total submissions
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.64LOEUF
pLI 0.000
Z-score -0.14
OE 1.04 (0.681.64)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.60Z-score
OE missense 0.88 (0.771.00)
165 obs / 188.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?1.04 (0.681.64)
00.351.4
Missense OE?0.88 (0.771.00)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 13 / 12.5Missense obs/exp: 165 / 188.2Syn Z: 0.12

This gene — mechanism propensity

DN
0.7034th %ile
GOF
0.5758th %ile
LOF
0.2775th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

53 submitted variants in ClinVar

Classification Summary

VUS36
Likely Benign5
Benign5
Conflicting1
36
VUS
5
Likely Benign
5
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
0
36
0
0
36
Likely Benign
0
5
0
0
5
Benign
1
0
1
3
5
Conflicting
1
Total1411347

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 13) ClinVar copy-number / structural variants overlap AIM2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

AIM2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Breast CancerBreast Cancer Female

SNAPS Breast Cancer Patient Study Breast Cancer Patients

NOT YET RECRUITING
NCT05370300Immunis.AIStarted 2025-09-01
Blood test
Benign Prostatic Hyperplasia (BPH)

Effects of TNF Blockade on Human BPH/LUTS

RECRUITING
NCT06062875Phase PHASE2Endeavor HealthStarted 2024-01-24
Adalimumab
Ureteropelvic Junction ObstructionChronic Kidney Diseases

The PRO-FUTURE Project

RECRUITING
NCT06382233University of Campania Luigi VanvitelliStarted 2024-01-30
Identification of Diagnostic Biomarkers
Maternal DistressChild Development

In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics

RECRUITING
NCT07296107Columbia UniversityStarted 2026-05-08
Prenatal maternal psychosocial and biological assessment protocol
Irritable Bowel Syndrome

Psyllium in Pediatric IBS

RECRUITING
NCT06639984Phase PHASE2Dr Bruno Chumpitazi, M.D.Started 2025-02-20
Psyllium (0.7 g/year of age per day)Psyllium (0.5 g/year of age per day)Placebo
THC

THC Titration of High-Potency Cannabis Concentrates

RECRUITING
NCT07105449Phase NACentre for Addiction and Mental HealthStarted 2025-10-01
Cannabis (30% THC Concentrate)Cannabis (60% THC Concentrate)Cannabis (90% THC Concentrate)
Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, Familial

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

RECRUITING
NCT05489549University of Texas Southwestern Medical CenterStarted 2022-11-21
Limbic Encephalitis With LGI1 Antibodies

Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease

RECRUITING
NCT06515106Phase NAFundacion Clinic per a la Recerca BiomédicaStarted 2023-12-18
Remote cognitive rehabilitation program
Anthracycline Related Cardiotoxicity in Breast Cancer

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

RECRUITING
NCT03934905Phase PHASE1, PHASE2Texas Tech University Health Sciences CenterStarted 2022-06-01
sulforaphanePlacebo Oral Tablet
Cancer EducationSpanish Language Cancer Education

Outreach Core Activities

RECRUITING
NCT05832177H. Lee Moffitt Cancer Center and Research InstituteStarted 2023-03-22
Cancer CientoUno (101) programLatinos y el cáncer/Hablemos de cáncer (Translation in English: Latinos and Cancer/Let's Talk About Cancer)¡Salud! Serie de Charlas (Translation in English: Health! Talk Series)
GliomaMalignant GliomaRecurrent Glioma

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

ACTIVE NOT RECRUITING
NCT05045027Phase EARLY_PHASE1Jonsson Comprehensive Cancer CenterStarted 2021-09-01
Biospecimen CollectionDiagnostic ImagingMagnetic Resonance Imaging
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

ACTIVE NOT RECRUITING
NCT06855394University of FloridaStarted 2011-01-01